Applications open for Youth for Tech Futures (YTF) Fellowship 2026! [Apply by December 15, 2025]

/ By / Opportunities

The Pranava Institute invites applications for its Youth for Tech Futures (YTF) Fellowship 2026! The fellowship will bring together a select cohort of ten research fellows (aged 18-27) to lead original, youth-driven research on how young Indians experience, navigate, and imagine their digital lives. YTF Fellowship is a fully paid program, with a generous fellowship stipend across the 4-month period of the fellowship. YTF fellows who complete the program will receive INR 1 Lakh as a take-home stipend. The last date […]

Applications open for Youth for Tech Futures (YTF) Fellowship 2026! [Apply by December 15, 2025] Read More »

Establishment of Permanent Subsidiary Body on Article 8(j) of the CBD: A New Direction for IPLCs and Traditional Knowledge Protection?

/ By / Biological Diversity

The CBD’s recent creation of a permanent body for Indigenous Peoples and Local Communities (SB8J) marks a significant shift in how global biodiversity governance engages with traditional knowledge. But does SB8J offer real change or just renewed symbolism? Achyuth B Nandan examines this question and looks at the implications of this development. Achyuth is a PhD candidate at Rajiv Gandhi School of Intellectual Property Law, IIT Kharagpur, specialising in intellectual property law. He is also a registered advocate with the

Establishment of Permanent Subsidiary Body on Article 8(j) of the CBD: A New Direction for IPLCs and Traditional Knowledge Protection? Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (08.12.2025)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles! A quick reminder: the SpicyIP–jhana Blogpost Writing Competition is still open — so if you’ve been meaning to write, this is your nudge! Bell of the Week: Open Source Drug Discovery (OSDD) Initiative Some Bells don’t just chime — they challenge the way we think. This week, I want to spotlight the Open Source Drug Discovery (OSDD) Initiative by CSIR, a path-breaking effort that reimagined how drug discovery could be done

SpicyIP Bells & Whistles: IP Events and Opportunities (08.12.2025) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (December 1 – December 7)

/ By / Copyright, Data Exclusivity, Others, Patent, Trademark

Starting the month with an analysis of the Delhi HC’s judgment in Novo v. Reddy in the Ozempic dispute. Section 3(k) in the news again in Ab Initio v. Controller, and a trademark battle over the word ‘choice’. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know.  Highlights of the Week Part I- Novo v. Dr. Reddy: Clear the Way or Else Block The Way

SpicyIP Weekly Review (December 1 – December 7) Read More »

Saying the Quiet Part Out Loud! – Analysing  Ab Initio Technology LLC v. Controller of Patents

/ By / Patent

Slightly long post…… The Madras High Court (MHC) has called a spade a spade. In Ab Initio Technology LLC v. Controller of Patents, MHC recognised and attempted to clarify the confusion surrounding Section 3(k). At various instances, we have highlighted that Section 3(k) jurisprudence has been plagued by terminological confusion, leading to fragmentation of jurisprudence and thus producing a cacophony of tests. It is admirable that MHC, for the first time, recognised the confusion surrounding Section 3(k) and some of

Saying the Quiet Part Out Loud! – Analysing  Ab Initio Technology LLC v. Controller of Patents Read More »

Part I- Novo v. Dr. Reddy: Clear the Way or Else Block The Way

/ By / Patent

Novo Nordisk v. Dr. Reddy was a dispute over the drug ‘semaglutide’, also marketed as Ozempic. In September 2025, WHO included semaglutide in the essential medicine list for treatment of type-2 diabetes. The patent over this drug is registered with Novo Nordisk which is yet to launch Ozempic in India. Although the Court upheld prima facie invalidityof Novo’s patent over semaglutide, it has, curiously, declined to allow the Defendant to sell the drug in India. Expectedly, Novo has rushed to launch the Ozempic in India this

Part I- Novo v. Dr. Reddy: Clear the Way or Else Block The Way Read More »

Original Sin: Why Inventing Abbreviations Distorts Trademark Law

/ By / Trademark

While the battle over the word ‘choice’ rages, some basic trademark principles are being forgotten. Even though the Supreme Court referred Allied Blenders and John Distillers to mediation, Aryan Agrawal, in this guest post, explains why it is not enough. He traces the trajectory of the dispute from the Madras High Court and shows how visual spectacles might have overridden core trademark principles. Aryan Agrawal is a final-year BA LLB (Hons.) student at Jindal Global Law School. He is also

Original Sin: Why Inventing Abbreviations Distorts Trademark Law Read More »

Reflections from an IP Weekend: The First Rajiv K. Luthra Memorial Lecture 2025 Delivered by Prof. Dev Gangjee

/ By / Copyright

The IP enthusiast in me had a great weekend after attending the First Rajiv K. Luthra Memorial Lecture on 29th November 2025, jointly organized by the National Law School of India University (NLSIU), Bengaluru, and the Rajiv K. Luthra Foundation (RKLF). Prof Dev Gangjee from University of Oxford delivered the lecture on the topic ‘Tools or Partners? Hybrid Human-AI Creativity and the Boundaries of Copyright’. Prof Gangjee was later joined by Eashan Ghosh, In-Charge IPR Chair at National Law University

Reflections from an IP Weekend: The First Rajiv K. Luthra Memorial Lecture 2025 Delivered by Prof. Dev Gangjee Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (November 24-November 30)

/ By / Copyright, Geographical Indication, Opportunities, Others, Patent, Trademark

India’s first scent trademark has been headline of the week – two posts discussing the development. A critical analysis of the Draft GI Logo Guidelines. And Episode 2 of “Let’s IPsa Loquitur” is up with Sonisha Srinivasan speaking to Dr Zakir Thomas. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know.  Highlights of the Week Let’s IPsa Loquitur: Dr. Zakir Thomas on Copyright, AI, Technology

SpicyIP Weekly Review (November 24-November 30) Read More »

DHC’s First: Does a Species (Automatically) Anticipate Genus?

/ By / Patent

Since Novartis v. UOI (2013), a growing litany of cases relating to genus-species patent have been decided by various HCs of the country. Post Novartis, a consistent (and contentious) issue has been whether a later species patent stood disclosed and, thus, priorly claimed in the prior genus patent u/s. 64(1)(a). However, the recent decision of the DHC in FMC Corporation v. Natco raises the inverse issue- does a prior species patent anticipate a later genus patent u/s. 64(1)(a)? This question, in my research, has not been previously decided by Indian Courts.  Facts Unlike previous genus-species

DHC’s First: Does a Species (Automatically) Anticipate Genus? Read More »

Scroll to Top